Roxane Agrees To Hold Off On Generic Asacol
Roxane Laboratories Inc. has agreed to delay its launch of a generic version of inflammatory bowel drug Asacol until as late as November as part of a discovery agreement in a...To view the full article, register now.
Already a subscriber? Click here to view full article